Primary Invasive Intestinal Aspergillosis in a Non-Severely Immunocompromised Patient
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Invasive aspergillosis (IA) is most commonly seen in patients with risk factors, such as cytotoxic chemotherapy, prolonged neutropenia, corticosteroids, transplantation and acquired immune deficiency syndrome. IA commonly occurs in the respiratory tract. Extrapulmonary aspergillosis is usually a part of a disseminated infection, and primary invasive intestinal aspergillosis is very rare. Herein, we report a case of an immunocompetent 53-year-old male who suffered recurrent septic shock in the intensive care unit (ICU) and was finally diagnosed as invasive intestinal aspergillosis without dissemination. IA is rarely considered for patients who do not have an immune disorder. Thus, when such cases do occur, the diagnosis is delayed and the clinical outcome is often poor. However, there is a growing literature reporting IA cases in patients without an immune disorder, mostly among ICU patients. Primary intestinal aspergillosis should be considered for critically ill patients, especially with severe disrupted gastrointestinal mucosal barrier.
Abstract
Invasive aspergillosis (IA) is most commonly seen in patients with risk factors, such as cytotoxic chemotherapy, prolonged neutropenia, corticosteroids, transplantation and acquired immune deficiency syndrome. IA commonly occurs in the respiratory tract. Extrapulmonary aspergillosis is usually a part of a disseminated infection, and primary invasive intestinal aspergillosis is very rare. Herein, we report a case of an immunocompetent 53-year-old male who suffered recurrent septic shock in the intensive care unit (ICU) and was finally diagnosed as invasive intestinal aspergillosis without dissemination. IA is rarely considered for patients who do not have an immune disorder. Thus, when such cases do occur, the diagnosis is delayed and the clinical outcome is often poor. However, there is a growing literature reporting IA cases in patients without an immune disorder, mostly among ICU patients. Primary intestinal aspergillosis should be considered for critically ill patients, especially with severe disrupted gastrointestinal mucosal barrier.
참고문헌 (12)
- Segal BH, "Aspergillosis", N Engl J Med, 360, pp.1870~1884 (2009)
- Meersseman W, "Invasive aspergillosis in the intensive care unit", Clin Infect Dis, 45, pp.205~216 (2007)
- Clancy CJ, "Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease", Chest, 114, pp.629~634 (1998)
- Eggimann P, "Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature", Infection, 34, pp.333~338 (2006)
- Stevens DA, "Aspergillosis in the ‘nonimmunocompromised’host", Immunol Invest, 40, pp.751~766 (2011)
- 차선아, "Invasive Primary Colonic Aspergillosis in the Immunocompetent Host without Classical Risk Factors", Yonsei Medical Journal, 56(5), pp.1453~1456 (2015), 연세대학교의과대학[DOI]
- Seong-Ho Choi, "A Case of Isolated Invasive Aspergillus Colitis Presenting with Hematochezia in a Nonneutropenic Patient with Colon Cancer", Gut and Liver, 4(2), pp.274~277 (2010), 거트앤리버 발행위원회
- Nivoix Y, "Factors associated with overall and attributable mortality in invasive aspergillosis", Clin Infect Dis, 47, pp.1176~1184 (2008)
- Hsu JL, "Diagnosing invasive fungal disease in critically ill patients", Crit Rev Microbiol, 37, pp.277~312 (2011)
- Pfeiffer CD, "Diagnosis of invasive aspergillosis using a galactomannan assay: a metaanalysis", Clin Infect Dis, 42, pp.1417~1427 (2006)
- Sulahian A, "False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam", N Engl J Med, 349, pp.2366~2367 (2003)
- Kazan E, "A retrospective series of gut aspergillosis in haematology patients", Clin Microbiol Infect, 17, pp.588~594 (2011)